Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Feb;32(1):47-56.
doi: 10.1007/s00292-010-1400-4.

[Pleomorphic high-grade soft tissue sarcomas: is the subclassification up to date?]

[Article in German]
Affiliations
Review

[Pleomorphic high-grade soft tissue sarcomas: is the subclassification up to date?]

[Article in German]
G Mechtersheimer et al. Pathologe. 2011 Feb.

Abstract

The conceptual evolution in the classification of pleomorphic high-grade sarcomas is a paradigm of how the integrative morphological, immunohistochemical and molecular genetic analysis has contributed to a clinical, prognostic and therapy-oriented characterization of this complex group of tumors. The clinical and prognostic relevance of a refined subtyping of pleomorphic high-grade sarcomas, which until recently was considered a mere academic exercise, is now undisputed. It is imperative to unequivocally differentiate sarcomas from non-sarcomatous, clearly defined malignancies to start adequate therapy. Furthermore, pleomorphic sarcomas which are particularly aggressive and prone to poor prognosis, have to be separated from sarcomas which, in contrast to the pleomorphic phenotype, are characterized by a less aggressive behavior. Also, morphologically pleomorphic but benign mesenchymal tumors must be recognized. Finally, it is important to promote the promising, array-based identification of diagnostic, prognostic and clinically relevant gene signatures on larger collections of pathomorphologically and clinically precisely defined subtypes of pleomorphic high-grade sarcomas.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Hum Pathol. 2010 May;41(5):663-71 - PubMed
    1. Genes Chromosomes Cancer. 2006 Sep;45(9):829-38 - PubMed
    1. Am J Surg Pathol. 1998 May;22(5):588-94 - PubMed
    1. Histopathology. 1998 Nov;33(5):414-24 - PubMed
    1. Mod Pathol. 2006 May;19(5):659-68 - PubMed

MeSH terms

Substances

LinkOut - more resources